Trial Profile
A Prospective Evaluation of Capecitabine and Metabolite Pharmacokinetics in Elderly Breast and Colorectal Cancer Patients and Their Association With Toxicity and Molecular Markers of Enzyme Activity and Aging
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2022
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary)
- Indications Breast cancer; Colorectal cancer
- Focus Pharmacokinetics
- 16 Mar 2018 New trial record